A 72-week Phase 3 trial (SURMOUNT-1) published in NEJM found tirzepatide 15mg produced mean body weight reduction of 20.9% vs 3.1% placebo, but lean mass accounted for 2540% of total weight lost without metabolic intervention
Improvement Timeline: 12 weeks : Antioxidant levels in semen start to improve
This product suits people who are already engaged with longevity protocols whether tracking NAD+ markers, working with a clinician on healthy ageing, or simply looking for a more direct delivery route than capsules
Many patients find they have more energy and endurance after a few weeks on AOD-9604, at which point gradually increasing exercise intensity makes sense
GLP-1s and HRT: The weight loss benefits of a combined approach Combining hormone replacement therapy (HRT) with GLP-1 medications is emerging as one of the most promising new strategies for managing weight and overall well-being during menopause
That's according to a recent survey from Evercore ISI focused on GLP-1s, a new class of medications used to treat Type 2 diabetes and obesity
